Selective Wealth Management’s Biogen BIIB Stock Holding History

Selective Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-567	Closed	-$151K	–	180
2022 Q3	$151K	Sell	567 -100	-15%	-$21.2K	0.06%	158
2022 Q2	$136K	Hold	667	–	–	0.05%	187
2022 Q1	$140K	Sell	667 -200	-23%	-$43.5K	0.05%	170
2021 Q4	$208K	Sell	867 -100	-10%	-$25.7K	0.08%	121
2021 Q3	$274K	Buy	967 +159	+20%	+$52.1K	0.15%	77
2021 Q2	$280K	Buy	+808	New	+$245K	0.22%	52

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Selective Wealth Management's BIIB Position: Q4 2022 in Review

Selective Wealth Management sold out of Biogen (BIIB) in Q4 2022, closing a stake of 567 shares — an estimated $151K sold.

Selective Wealth Management first reported a position in BIIB in Q2 2021 and held it in 6 quarters. The position peaked at $280K in Q2 2021. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

Selective Wealth Management reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
Selective Wealth Management sold 567 Biogen shares in Q4 2022, an estimated $151K.
Selective Wealth Management first reported a position in Biogen in Q2 2021 and held it in 6 quarters.
Selective Wealth Management's Biogen position peaked at $280K in Q2 2021.
1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Selective Wealth Management's 13F filing for Q4 2022, filed 23 Jan 2023.